saaf

VTRS

Viatris Inc

Non-compliant
Sector
Healthcare
Industry
Drug Manufacturers - General
Score
0/100
Data as of
2026-02-26
Figures are read automatically from SEC filings — tap any number to verify the source.
How is this score computed?

Non-compliant and needs-review verdicts always score 0, regardless of any ratio — so nothing built on top of this engine treats them as safe by default.

  • Interest income not separately disclosed in filings; assumed immaterial (cash+securities / market cap = 9.4% < 20%).

Price

Screening standard

How the verdict was computed

  • Business activity

    Business activity is compliant.

  • Debt vs. market cap102.44% vs limit 33.00%

    interest-bearing debt / market cap = 102.44% (≥ 33% limit).

  • Interest income vs. revenue

    Interest income not separately disclosed; assumed immaterial (cash+securities / market cap = 9.4% < 20% threshold).

  • Cash & interest-bearing assets vs. market cap9.40% vs limit 33.00%

    (cash + interest-bearing securities) / market cap = 9.40% (< 33% limit).

Every number, sourced

Figures read directly from SEC EDGAR XBRL facts. Don't trust us — verify.

FigureValue (as filed)FilingSource
Total revenueRevenue from contract with customer excluding assessed tax$14.3B10-K · 2026-02-26View filing ↗
Interest-bearing debt· 3 components$14.4B10-K · 2026-02-26View filing ↗
Long term debt noncurrent$12.5B
Long term debt current$1.9B
Short term borrowings$0
Cash & interest-bearing securitiesCash and cash equivalents at carrying value$1.3B10-K · 2026-02-26View filing ↗
Total assetsAssets$37.2B10-K · 2026-02-26View filing ↗
ReceivablesAccounts receivable net current$3.0B10-K · 2026-02-26View filing ↗
Shares outstandingEntity common stock shares outstanding1.2B shares10-Q · 2026-05-07View filing ↗
Priceyahoo:24mo-trailing-avg$12.082market

Values & Controversies

Separate from the shariah verdict above — always.

No flags. This company isn't on the BNC (Boycott National Committee) priority or divestment lists, or any grassroots BDS-supported campaign we track.